European Archives - Page 172 of 999 - European Medical Journal

Virtual Reality: A New Treatment Modality – Part 1

Focused on virtual reality’s use in healthcare, this episode explores the effects of virtual reality on the human mind.

Minor Ground-Glass Opacity Component Enhances Lung Cancer Prognosis

New research has linked improved outcomes in patients with lung cancer with the presence of ground-glass opacities.

AI Predicts Functional Outcomes in High-Grade Glioma Patients

Helping clinicians forsee surgical outcomes, a new study leveraged machine-learning algorithm for high-grade glioma patients.

Increased Risk of Arrhythmias in Females with Pre-eclampsia

Pre-eclampsia is associated with a higher risk of arrhythmias in primiparous females, according to new research.

Are patients with PBC best served by the current regulatory approval model?

PBC experts Prof Dave Jones and Prof Gideon Hirschfield discuss the newest developments and regulatory challenges in advancing treatment…

JAK Inhibitors: A New Frontier in Dermatology

JAK INHIBITORS have changed dermatology, and will continue to change dermatology in ways that no other class of drugs has…

Nasal Tip Flap: Effective Reconstruction for Nose Cancers

A study analysed 66 cases where a nasal tip rotation flap was employed for reconstruction after skin cancer.

Rising Oral Retinoid Use Among Women Lacks Contraceptive Safeguarding

There is a concerning trend as the use of oral retinoids among women is rising, yet many are not using necessary contraceptive measures to mitigate the associated teratogenic risks.

Almirall's Mercedes Diz on dreaming big and testing your limits

Mercedes Diz, Chief Marketing Officer, Almirall, talks about pushing your limits to achieve your goals and how to be more patient centric.

The word spotlight on a blue background with the 'o' as a spotlight circle

Spotlight: May 2024

Catch up on May’s top pharma news in this monthly round-up. From the latest HCP insights on pharma companies to new investments, there’s plenty to discover.